Literature DB >> 2028222

Rhodococcus equi--an easily missed opportunistic pathogen.

C Doig1, M J Gill, D L Church.   

Abstract

Over the last 10 years Rhodococcus equi has been identified as an important, albeit very rare, opportunistic pathogen. As the number of patients immunocompromised from HIV infection grows, this microorganism will likely become of increasing clinical importance. Infection with R. equi is usually insidious, causing progressive pulmonary disease that is typically pleural based at the time of microbiological diagnosis. As in the case we present, the clinical and microbiological diagnoses may be significantly delayed, either by the common pitfalls encountered in the laboratory identification of R. equi, or by the failure to recognize the pathogenic potential of the isolate. R. equi infection should be suspected in immunocompromised patients with pneumonia, when a pure or predominant growth of aerobic, non-sporeforming gram-positive bacilli is found on cultures of bronchoalveolar lavage fluid and other pulmonary pathogens have been excluded.

Entities:  

Mesh:

Year:  1991        PMID: 2028222     DOI: 10.3109/00365549109023367

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  9 in total

1.  Role of CD4+, CD8+ and double negative T-cells in the protection of SCID/beige mice against respiratory challenge with Rhodococcus equi.

Authors:  T L Ross; G A Balson; J S Miners; G D Smith; P E Shewen; J F Prescott; J A Yager
Journal:  Can J Vet Res       Date:  1996-07       Impact factor: 1.310

2.  Failure of pulmonary clearance of Rhodococcus equi infection in CD4+ T-lymphocyte-deficient transgenic mice.

Authors:  S T Kanaly; S A Hines; G H Palmer
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

Review 3.  The medically important aerobic actinomycetes: epidemiology and microbiology.

Authors:  M M McNeil; J M Brown
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

4.  Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens.

Authors:  M M McNeil; J M Brown
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

5.  Transfer of a CD4+ Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung.

Authors:  S T Kanaly; S A Hines; G H Palmer
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

6.  The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells.

Authors:  M K Hondalus; M S Diamond; L A Rosenthal; T A Springer; D M Mosser
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

7.  Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia.

Authors:  S T Kanaly; S A Hines; G H Palmer
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

Review 8.  Rhodococcus equi and Arcanobacterium haemolyticum: two "coryneform" bacteria increasingly recognized as agents of human infection.

Authors:  R Linder
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

9.  Pyogranulomatous skin disease and cellulitis in a cat caused by Rhodococcus equi.

Authors:  A Patel
Journal:  J Small Anim Pract       Date:  2002-03       Impact factor: 1.522

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.